Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK3882347 in females with acute uncomplicated UTI
NCT05138822Phase 1Completed
- Sponsor
- GSK
- Start
- May 2022
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of GSK3882347 in urinary tract infection (UTI), sponsored by GSK. Primary endpoint: Number of Participants With Microbiological Response at the Test of Cure (ToC) Visit. Started May 2022; status: completed.
02
Drugs
GSK3882347
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT05138822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05138822.